Axel Mark Inc., together with its subsidiaries, engages in the advertising, trading card, IoT healthcare, and blockchain-related businesses in Japan. It operates through Advertising Business, Trading Card Business, and Others segments. The company offers advertising network services that network various internet advertising media; sells advertising space; receives commissions; and operates a trading desk that manages advertising. It also provides ADroute, an ad network service; AXEL MARK DSP, an ad distribution platform that allows real-time bidding for ad space; EC MARK, a specialized e-commerce service that supports sales promotion for e-commerce businesses; TRADING DESK, an advertising management service that specializes in optimizing performance-based advertising; and BRAND SCREEN, a service that delivers brand advertising. In addition, the company is involved in the planning, development, and sale of IoT solutions, such as automatic snow depth automatic monitoring systems under the name YUKIMI; and mobile communication systems. Further, it engages in the manufacture and sale of medical equipment, reagents, and beauty and health equipment, etc.; development of blockchain games, apps, and XR; web and system production; contract development, operation, and maintenance of systems; and operation of trading card specialty stores and e-commerce sites. Axel Mark Inc. was incorporated in 1994 and is headquartered in Nakano, Japan.
Price
ยฅ62
Market Cap
ยฅ1.2B
Ent. Value
ยฅ309M
Net Cash
ยฅ899M
Shares Out.
19.5M
P / E
โ
EV / EBIT
โ
P / Book
1.52ร
P / NCAV
2.11ร
Div. Yield
โ
PRICE
Historical Valuation Mapping
ANNUAL BASES VS. DAILY MULTIPLES
1Yr
3Yr
5Yr
Max
ANNUAL HISTORICAL EPS (ยฅ)
VALUATION MULTIPLE (P/E)
DAILY PRICING LOGS VIA YAHOO FINANCE
โข
HISTORICAL FUNDAMENTALS COMPILATION VIA EDINET
| Metric |
FY 2025
EDINET โ |
FY 2024
EDINET โ |
FY 2023
EDINET โ |
FY 2022
EDINET โ |
FY 2021
EDINET โ |
|---|---|---|---|---|---|
| Net Sales | ยฅ974M | ยฅ1.6B | ยฅ2.1B | ยฅ2.7B | ยฅ2.7B |
| Cost of Sales | ยฅ869M | ยฅ1.5B | ยฅ1.9B | ยฅ2.4B | ยฅ2.3B |
| Gross Profit | ยฅ105M | ยฅ89M | ยฅ222M | ยฅ318M | ยฅ316M |
| SG&A | ยฅ625M | ยฅ395M | ยฅ320M | ยฅ305M | ยฅ313M |
| Operating Income | ยฅ-520M | ยฅ-305M | ยฅ-99M | ยฅ13M | ยฅ3M |
| Non-Operating Income | ยฅ15M | ยฅ57M | ยฅ5M | ยฅ5M | ยฅ55M |
| Interest Income | ยฅ3M | ยฅ1M | ยฅ1M | ยฅ1M | ยฅ1M |
| Non-Operating Expenses | ยฅ167M | ยฅ2M | ยฅ6M | ยฅ8M | ยฅ16M |
| Interest Expense | ยฅ0M | โ | โ | โ | ยฅ0M |
| Ordinary Income | ยฅ-672M | ยฅ-250M | ยฅ-101M | ยฅ10M | ยฅ42M |
| Pre-tax Income | ยฅ-767M | ยฅ-388M | ยฅ-101M | ยฅ-96M | ยฅ80M |
| Income Taxes | ยฅ-3M | ยฅ1M | ยฅ1M | ยฅ5M | ยฅ5M |
| Current Tax | ยฅ2M | ยฅ1M | ยฅ1M | ยฅ5M | ยฅ5M |
| Deferred Tax | ยฅ-6M | โ | โ | โ | โ |
| Net Income (owners) | ยฅ-763M | ยฅ-389M | ยฅ-102M | ยฅ-101M | ยฅ75M |
| Comprehensive Income | ยฅ-780M | โ | โ | โ | โ |
| EBITDA | ยฅ-512M | ยฅ-289M | ยฅ-92M | ยฅ17M | ยฅ8M |
| Goodwill Amort. (J-GAAP) | ยฅ6M | โ | โ | โ | โ |
| EPS | ยฅ-49.58 | ยฅ-36.50 | ยฅ-9.63 | ยฅ-10.24 | ยฅ9.70 |
| Shares Outstanding | 19.5M | 10.6M | 10.6M | 10.6M | 9.4M |
| Shares Issued (total) | 19.5M | 10.6M | 10.6M | 10.6M | 9.4M |
| Metric |
FY 2025
EDINET โ |
FY 2024
EDINET โ |
FY 2023
EDINET โ |
FY 2022
EDINET โ |
FY 2021
EDINET โ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | ยฅ1.3B | ยฅ925M | ยฅ1.4B | ยฅ1.6B | ยฅ1.7B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Assets | ยฅ1.1B | ยฅ675M | ยฅ1.2B | ยฅ1.5B | ยฅ1.5B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Deposits | ยฅ919M | ยฅ511M | ยฅ906M | ยฅ1.2B | ยฅ1.1B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade Receivables | ยฅ66M | ยฅ66M | ยฅ188M | ยฅ198M | ยฅ326M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Assets | ยฅ232M | ยฅ251M | ยฅ240M | ยฅ84M | ยฅ191M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PP&E | ยฅ19M | โ | ยฅ11M | ยฅ14M | ยฅ17M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill | ยฅ63M | โ | โ | โ | โ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets | ยฅ72M | โ | ยฅ100M | ยฅ1M | ยฅ2M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment Securities | ยฅ85M | ยฅ38M | ยฅ153M | ยฅ158M | ยฅ151M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Assets | ยฅ12M | โ | โ | โ | โ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ยฅ521M | ยฅ458M | ยฅ568M | ยฅ625M | ยฅ1.0B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Liabilities | ยฅ500M | ยฅ100M | ยฅ212M | ยฅ246M | ยฅ306M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ST Debt | โ | ยฅ0M | ยฅ0M | ยฅ0M | ยฅ0M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taxes Payable | ยฅ19M | ยฅ1M | ยฅ0M | ยฅ7M | ยฅ7M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Liabilities | ยฅ21M | ยฅ358M | ยฅ357M | ยฅ379M | ยฅ713M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total LT Borrowings | ยฅ20M | ยฅ0M | ยฅ0M | ยฅ0M | ยฅ0M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Liab. | ยฅ2M | ยฅ1M | โ | โ | โ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | ยฅ805M | ยฅ467M | ยฅ854M | ยฅ935M | ยฅ692M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Stock | ยฅ627M | ยฅ61M | ยฅ61M | ยฅ217M | ยฅ493M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Surplus | ยฅ1.5B | ยฅ886M | ยฅ886M | ยฅ808M | ยฅ393M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retained Earnings | ยฅ-1.3B | ยฅ-491M | ยฅ-102M | ยฅ-101M | ยฅ-195M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury Stock | ยฅ-0M | ยฅ-0M | ยฅ-0M | ยฅ-0M | ยฅ-0M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AOCI | ยฅ3M | ยฅ3M | ยฅ3M | ยฅ4M | ยฅ-5M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity (owners) | ยฅ793M | ยฅ456M | ยฅ845M | ยฅ925M | ยฅ691M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Interest-Bearing Debt โ | ยฅ20M | ยฅ0M | ยฅ0M | ยฅ0M | ยฅ0M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Cash โ | ยฅ899M | ยฅ511M | ยฅ906M | ยฅ1.2B | ยฅ1.1B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV โ | ยฅ573M | ยฅ217M | ยฅ614M | ยฅ851M | ยฅ501M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV/Share | ยฅ29 | ยฅ20 | ยฅ58 | ยฅ80 | ยฅ53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BV/Share | ยฅ41 | ยฅ43 | ยฅ79 | ยฅ87 | ยฅ73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metric |
FY 2025
EDINET โ |
FY 2024
EDINET โ |
FY 2023
EDINET โ |
FY 2022
EDINET โ |
FY 2021
EDINET โ |
|---|---|---|---|---|---|
| Operating CF | ยฅ-467M | ยฅ-288M | ยฅ-173M | ยฅ94M | ยฅ-14M |
| Interest Paid | ยฅ-0M | โ | โ | โ | ยฅ-1M |
| Interest Received | ยฅ3M | ยฅ1M | ยฅ1M | ยฅ1M | ยฅ1M |
| D&A | ยฅ3M | ยฅ16M | ยฅ7M | ยฅ4M | ยฅ5M |
| Goodwill Amort. | ยฅ6M | โ | โ | โ | โ |
| Investing CF | ยฅ-234M | ยฅ-108M | ยฅ-162M | ยฅ7M | ยฅ89M |
| CapEx | ยฅ20M | ยฅ0M | ยฅ0M | ยฅ0M | ยฅ0M |
| Purchase Investments | ยฅ-50M | ยฅ-143M | โ | โ | ยฅ-109M |
| Financing CF | ยฅ1.1B | ยฅ1M | ยฅ1M | ยฅ0M | ยฅ812M |
| LT Debt Repaid | ยฅ-2M | โ | โ | โ | ยฅ-150M |
| Free Cash Flow | ยฅ-486M | ยฅ-288M | ยฅ-173M | ยฅ94M | ยฅ-14M |
| Net Change in Cash | ยฅ408M | ยฅ-395M | ยฅ-334M | ยฅ101M | ยฅ888M |
| Metric |
FY 2025
EDINET โ |
FY 2024
EDINET โ |
FY 2023
EDINET โ |
FY 2022
EDINET โ |
FY 2021
EDINET โ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Equity (ROE) โ | -120.0% | -58.8% | -11.4% | -12.4% | 10.8% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Assets (ROA) โ | -67.8% | -33.1% | -6.9% | -6.2% | 4.4% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin โ | 10.8% | 5.6% | 10.3% | 11.9% | 11.9% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Margin โ | -53.4% | -19.3% | -4.6% | 0.5% | 0.1% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Margin โ | -78.4% | -24.5% | -4.8% | -3.8% | 2.8% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liquidity Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Ratio โ | 2.19x | 6.76x | 5.58x | 5.99x | 4.96x | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quick Ratio โ | 2.19x | 6.76x | 5.58x | 5.99x | 4.96x | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Per Share Metrics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue / Share โ | ยฅ50 | ยฅ149 | ยฅ201 | ยฅ253 | ยฅ281 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BV/Share โ | ยฅ41 | ยฅ43 | ยฅ79 | ยฅ87 | ยฅ73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV/Share โ | ยฅ29 | ยฅ20 | ยฅ58 | ยฅ80 | ยฅ53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS โ | ยฅ-49.58 | ยฅ-36.50 | ยฅ-9.63 | ยฅ-10.24 | ยฅ9.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DPS โ | ยฅ0.00 | ยฅ0.00 | ยฅ0.00 | ยฅ0.00 | ยฅ0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payout Ratio โ | โ | โ | โ | โ | 0.0% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FCF/Share โ | ยฅ-24.95 | ยฅ-27.08 | ยฅ-16.24 | ยฅ8.85 | ยฅ-1.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Valuation
Avg daily close price for calendar year ร most recently reported EPS / DPS
| Metric | CY2023 | CY2024 | CY2025 |
|---|---|---|---|
| Avg P/E โ |
27.6ร
EPS from 2021-09 |
โ | โ |
| Avg Div Yield โ |
0.00%
DPS from 2023-09 |
0.00%
DPS from 2024-09 |
0.00%
DPS from 2025-09 |
| Avg Daily Close | ยฅ268 | ยฅ187 | ยฅ121 |
Growth Rates (CAGR)
| Metric | 3yr CAGR (FY2022โ2025) | 5yr CAGR |
|---|---|---|
| Stock Price | -39.1% | -32.1% |
| Sales | -28.6% | โ |
| FCF/Share | โ | โ |
| EPS | โ | โ |
| DPS | โ | โ |
| BV/Share | -22.5% | โ |
| NCAV/Share | -28.5% | โ |
EVENT TIMELINE
S Shareholder
A Capital Signal
No capital allocation signals recorded for this company.
| # | Shareholder | Shares (thou.) | % of Total |
|---|---|---|---|
| 1 | ๆฐๆฒผ ๅพๅฒ | 1,500,000 |
|
| 2 |
Rakuten Securities, Inc.
ๆฅฝๅคฉ่จผๅธๆ ชๅผไผ็คพ
|
451,000 |
|
| 3 | ็ฌ่ณ ้ ๅผฅ | 400,000 |
|
| 4 | ใฆใฃใบ AIoT ใจใใชใฅใผใทใงใณใใกใณใๆ่ณไบๆฅญๆ้่ฒฌไปป็ตๅ | 318,800 |
|
| 5 | BNY GCM CLIENT ACCOUNT JPRD AC ISG(FE-AC)(ๅธธไปปไปฃ็ไบบ ๆ ชๅผไผ็คพไธ่ฑ๏ผต๏ผฆ๏ผช้่ก๏ผ | 281,813 |
|
| 6 |
SBI Securities Co., Ltd.
ๆ ชๅผไผ็คพ๏ผณ๏ผข๏ผฉ่จผๅธ
|
266,500 |
|
| 7 | ๅพ่ค ใฟใฉใ | 250,500 |
|
| 8 | ้ปๆจ ็ดๅ | 240,000 |
|
| 9 | ๆฐดไธ ๅบๅฟ | 234,000 |
|
| 10 |
Japan Securities Finance Co., Ltd.
ๆฅๆฌ่จผๅธ้่ๆ ชๅผไผ็คพ
|
213,000 |
|
as of 2025-09-30
Source: EDINET โ
Ownership by year โ hover bars for detail
Domestic Nominees
0.0%
+0.0% vs 2024
Trust bank custodians โ GPIF, pensions, investment trusts
Foreign Custodians
0.0%
+0.0% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
21.3%
-7.5% vs 2024
Named entities with disclosed investment intent
Bar = % of shares outstanding ยท top-10 covers 21.3% ยท grey = other shareholders ยท 2025
| Shareholder | Trend | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ๆฐๆฒผ ๅพๅฒ NEW ENTRY | โ | โ | โ | โ | โ | 7.69% NEW |
|
Rakuten Securities, Inc.
ๆฅฝๅคฉ่จผๅธ
|
โ | 2.50% | 1.87% | 2.21% | 2.31% +0.10% | |
| ็ฌ่ณ ้ ๅผฅ NEW ENTRY | โ | โ | โ | โ | โ | 2.05% NEW |
| ใฆใฃใบ AIoT ใจใใชใฅใผใทใงใณใใกใณใๆ่ณไบๆฅญๆ้่ฒฌไปป็ตๅ NEW ENTRY | โ | โ | โ | โ | โ | 1.64% NEW |
| BNY GCM CLIENT ACCOUNT JPRD AC ISG(FE-AC) NEW ENTRY | โ | โ | โ | โ | โ | 1.45% NEW |
|
SBI Securities Co., Ltd.
SBI่จผๅธ
|
โ | 4.11% | 3.79% | 2.11% | 1.37% -0.74% | |
| ๅพ่ค ใฟใฉใ NEW ENTRY | โ | โ | โ | โ | โ | 1.29% NEW |
| ้ปๆจ ็ดๅ | โ | โ | 1.27% | 1.32% | 1.23% -0.09% | |
| ๆฐดไธ ๅบๅฟ | โ | 1.07% | 1.22% | 1.27% | 1.20% -0.07% | |
|
Japan Securities Finance Co., Ltd.
NEW ENTRY
ๆฅๆฌ่จผๅธ้่
|
โ | โ | 1.04% | โ | 1.09% NEW | |
| ใฆใฃใบ AIoT ใจใใชใฅใผใทใงใณ ใใกใณใๆ่ณไบๆฅญๆ้่ฒฌไปป็ตๅ last seen 2024 | Exited Top 10 | 14.26% | 12.72% | 11.98% | 11.98% | โ |
| THEใฑใณใณใฆFUTUREๆ่ณไบๆฅญๆ้่ฒฌไปป็ตๅ last seen 2024 | Exited Top 10 | 4.26% | 3.85% | 3.92% | 3.92% | โ |
| ไฝ่ค ๆๅ last seen 2024 | Exited Top 10 | โ | โ | โ | 1.71% | โ |
| ๅฐพไธ ้ ๆฒป last seen 2024 | Exited Top 10 | 1.75% | 1.56% | 1.55% | 1.55% | โ |
| ไบๅณ ๅคง่ผ last seen 2024 | Exited Top 10 | 2.43% | 2.18% | 2.16% | 1.45% | โ |
| ๅๅคๅท ๅคง last seen 2024 | Exited Top 10 | โ | โ | 1.24% | 1.32% | โ |
| ๅฎฎๆ ๅ้ฆฌ last seen 2021 | Exited Top 10 | 0.94% | โ | โ | โ | โ |
| ๅคงไธ ๆญ last seen 2022 | Exited Top 10 | โ | 0.90% | โ | โ | โ |
|
Matsui Securities Co., Ltd.
ๆพไบ่จผๅธ
last seen 2022
|
Exited Top 10 | 0.95% | 1.31% | โ | โ | โ |
| ๅทๆฌ ๅฐๅพ last seen 2021 | Exited Top 10 | 1.48% | โ | โ | โ | โ |
| ๆจชๅฑฑ ่ฑไฟ last seen 2022 | Exited Top 10 | 1.13% | 0.96% | โ | โ | โ |
| ๆธก้ ๆฏ last seen 2021 | Exited Top 10 | 1.16% | โ | โ | โ | โ |
| ๅทๅฑฑ ็จ last seen 2021 | Exited Top 10 | 1.53% | โ | โ | โ | โ |
| Concentration (HHI) โ | 239 | 212 | 190 | 181 | 81 |
5 fiscal years ยท top-10 holders per year ยท >2,500 HHI = high concentration ยท entity-resolved
Material Events (4)
View on feed โ
| Date | Category | Summary | Amount | |
|---|---|---|---|---|
| 2026-03-13 |
๐ค M&A
Divestiture
|
The company resolved on March 13, 2026 to divest all shares of its subsidiary Wellness More Laboratories Co., Ltd., causing it to cease being a specified subsidiary. The divestiture follows a post-acquisition reassessment that revealed uncertainties in the subsidiary's growth prospects and limited synergies with the parent company's core operations.
|
โ | โบ |
|
Summary
The company resolved on March 13, 2026 to divest all shares of its subsidiary Wellness More Laboratories Co., Ltd., causing it to cease being a specified subsidiary. The divestiture follows a post-acquisition reassessment that revealed uncertainties in the subsidiary's growth prospects and limited synergies with the parent company's core operations.
Source (JP)
โ EDINET
ๅฝ็คพใฏ2026ๅนด๏ผๆ13ๆฅไปใฎๅ็ท ๅฝนไผใซใใใฆใใฆใงใซใในใขใขใฉใใฉใใชใผใบๆ ชๅผไผ็คพใฎๅ
จๆ ชๅผใ่ญฒๆธกใใใใจใซใคใใฆๆฑบ่ญฐใใใใพใใใ
|
||||
| 2026-03-13 |
๐ค M&A
Divestiture
|
The company has decided to divest all shares of its subsidiary Spiral Sense Inc., which will result in the subsidiary ceasing to be a specified subsidiary. The divestiture is scheduled for March 31, 2026, and is intended to optimize the company group's management resources and maximize enterprise value by allowing Spiral Sense to develop under new ownership.
|
โ | โบ |
|
Summary
The company has decided to divest all shares of its subsidiary Spiral Sense Inc., which will result in the subsidiary ceasing to be a specified subsidiary. The divestiture is scheduled for March 31, 2026, and is intended to optimize the company group's management resources and maximize enterprise value by allowing Spiral Sense to develop under new ownership.
Counterparty: Not disclosed
Source (JP)
โ EDINET
ๅฝ็คพใฏ2026ๅนด๏ผๆ13ๆฅไปใฎๅ็ท ๅฝนไผใซใใใฆใในใใคใฉใซใปใณในๆ ชๅผไผ็คพใฎๅ
จๆ ชๅผใ่ญฒๆธกใใใใจใซใคใใฆๆฑบ่ญฐใใใใพใใใ็ฐๅใฎๅนดๆๆฅ๏ผ2026ๅนด๏ผๆ31ๆฅ๏ผไบๅฎ๏ผ
|
||||
| 2026-02-12 |
๐ฅ Financial
Impairment
|
The company recorded a 36 million yen special loss from early redemption of convertible bonds issued in April 2021, and an additional 25 million yen loan loss provision for loans to subsidiary Axel Medica Co., Ltd. The loan loss provision is eliminated in consolidated accounting and does not impact consolidated earnings.
|
ยฅ61M | โบ |
|
Summary
The company recorded a 36 million yen special loss from early redemption of convertible bonds issued in April 2021, and an additional 25 million yen loan loss provision for loans to subsidiary Axel Medica Co., Ltd. The loan loss provision is eliminated in consolidated accounting and does not impact consolidated earnings.
Counterparty: Axel Medica Co., Ltd. (subsidiary)
Source (JP)
โ EDINET
2021ๅนด๏ผๆ28ๆฅใซ็บ่กใใ็ฌฌ๏ผๅ็กๆ
ไฟ่ปขๆ็คพๅตๅๆฐๆ ชไบ็ดๆจฉไป็คพๅตใฎ็นฐไธๅ้ใซไผดใใ36็พไธๅใ็นๅฅๆๅคฑใจใใฆ่จไธใใใใพใใใๅฝ็คพ้ฃ็ตๅญไผ็คพใงใใใขใฏใปใซใกใใฃใซๆ ชๅผไผ็คพใซๅฏพใใ่ฒธไป้ใซใคใใฆใ่ฒธๅๅผๅฝ้็นฐๅ
ฅ้ก25็พไธๅใ็นๅฅๆๅคฑใซ่จไธใใใใพใใใ
|
||||
| 2026-01-22 |
๐ค M&A
Acquisition
|
The company's board of directors resolved on January 22, 2026, to acquire all shares of Wellness More Laboratories Inc. by exercising share acquisition warrants attached to convertible bonds and purchasing 100 shares from existing shareholders, thereby making the company a wholly-owned subsidiary. This acquisition qualifies as a material subsidiary change requiring disclosure under the Financial Instruments and Exchange Act.
|
โ | โบ |
|
Summary
The company's board of directors resolved on January 22, 2026, to acquire all shares of Wellness More Laboratories Inc. by exercising share acquisition warrants attached to convertible bonds and purchasing 100 shares from existing shareholders, thereby making the company a wholly-owned subsidiary. This acquisition qualifies as a material subsidiary change requiring disclosure under the Financial Instruments and Exchange Act.
Counterparty: Wellness More Laboratories Inc. (ใฆใงใซใในใขใขใฉใใฉใใชใผใบๆ ชๅผไผ็คพ)
Source (JP)
โ EDINET
ใฆใงใซใในใขใขใฉใใฉใใชใผใบๆ ชๅผไผ็คพใๅฝ็คพใซๅฏพใใฆ็บ่กใใฆใใ่ปขๆ็คพๅตๅๆฐๆ ชไบ็ดๆจฉไป็คพๅตใซไปใใใๆฐๆ ชไบ็ดๆจฉใฎ่กไฝฟใใใณๅ็คพๆ ชไธปใใๅ็คพๆ ชๅผ100ๆ ชใ่ญฒใๅใใใใจใงใๅ
จๆ ชๅผใๅๅพใใๅ็คพใฎๅฎๅ
จๅญไผ็คพๅใๅๆใจใใๆ็ถใใ้ฒใใ
|
||||